Akari Therapeutics (AKTX) Shares Repurchased (2023 - 2024)
Akari Therapeutics recorded quarterly Shares Repurchased of $28000.0 in Q4 2024, up 7.69% quarter-over-quarter from $26000.0 in Q3 2024.
Akari Therapeutics' Shares Repurchased history runs 2 years deep, the most recent figure standing at $28000.0 for Q4 2024.
- In Q4 2024, Shares Repurchased changed N/A year-over-year to $28000.0; the TTM figure through Dec 2024 stood at $28000.0 (changed N/A YoY), while the FY2024 annual figure was $28000.0, up 600.0% from the prior year.
- Shares Repurchased came in at $28000.0 for Q4 2024 at Akari Therapeutics, up from $26000.0 in the prior quarter.
- In the past five years, Shares Repurchased ranged from a high of $28000.0 in Q4 2024 to a low of -$29000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 336.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 794.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |